2022 American Transplant Congress
Excessive Weight Gain Does Not Associate with Poorer Graft Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients – A Single-Center Experience
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Weight gain is common following organ transplantation, and there exists concern that in simultaneous pancreas-kidney (SPK) recipients, this may lead to poorer graft outcomes.*Methods:…2022 American Transplant Congress
Transplant Coordinator Time Saved (TCTS) Through a Hybrid On Call Team for Deceased Donor Kidney and Pancreas Transplant Organ Offers
Division of Kidney and Pancreas Transplantation, UC Irvine, Orange, CA
*Purpose: The purpose of this analysis was to estimate transplant coordinator time saved (TCTS) through the implementation of a hybrid on call team. Historically, transplant…2022 American Transplant Congress
Everolimus versus Mycophenolate in Simultaneous Pancreas and Kidney Transplantation: Progression of Diabetic Retinopathy in a Prospective Randomized Trial
*Purpose: mTOR inhibitors are known for their antiangiogenic effect. We compared the impact of everolimus (E) and mycophenolic acid (MPA) on the course of diabetic…2022 American Transplant Congress
Post-Transplant Lymphoproliferative Disorder in Kidney and Simultaneous Pancreas and Kidney Transplant Recipients Predictors, and Patient and Allograft Outcomes
*Purpose: Post-transplant lymphoproliferative disorder (PTLD) is a devastating complication following kidney and pancreas transplantation. 12% of UNOS waitlisted candidates had previous transplant and 20% are…2022 American Transplant Congress
Similar Outcomes in Type 2 Diabetic vs Type 1 Diabetics Receiving Simultaneous Kidney Pancreas Transplantation
1Mayo Clinic, Phoenix, AZ, 2Mayo Clinic, Rochester, MN
*Purpose: Combined kidney-pancreas transplant remains an optimal choice for type 1 diabetics with kidney failure. The benefit for those with type 2 diabetes, however, remains…2022 American Transplant Congress
An Initial Analysis of Baseline Levels of Dd-cfdna After Pancreas Transplantation: A Prospective Study from High-Volume Centers in the United States
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) testing, which has been validated for monitoring kidney transplant (KTx) rejection, may provide an alternative to pancreas biopsy that prevents…2022 American Transplant Congress
Is BK After SPK Okay?: Kidney and Pancreas Transplant Outcomes After BK Viremia
*Purpose: BK viremia and BK nephropathy (BKN) are common after kidney transplant alone, occurring in ~15% and ~1-10%, and are associated with an increased risk…2022 American Transplant Congress
Survival Comparison of Simultaneous Pancreas-Kidney Transplant with Pancreas After Living-Donor Kidney Transplant by Wait Time and Organ Quality
*Purpose: The survival benefit of simultaneous pancreas-kidney (SPK) compared to pancreas after living-donor kidney (PALK) transplant is controversial. Wait times for SPK and donor risk…2022 American Transplant Congress
Association of Physical Function and Depression Among Kidney-Pancreas Transplant Recipients Using PROMIS CATs
1University Health Network, Toronto, ON, Canada, 2Toronto General Hospital, Toronto, ON, Canada
*Purpose: The number of kidney-pancreas (KP) transplants is increasing accounting for approximately 6% of all kidney transplants in Canada. In addition to kidney failure and…2022 American Transplant Congress
Three‐Month Pancreas Graft Function Significantly Influences Survival Following Simultaneous Pancreas‐Kidney Transplantation in Type 1 Diabetes Patients
1Washington University in St. Louis, Saint Louis, MO, 2Saint Louis University, Saint Louis, MO
*Purpose: Simultaneous pancreas-kidney transplantation (SPK) is the only persistently successful treatment option for patients with diabetes mellitus and end-stage renal disease. However, SPK carries a…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 16
- Next Page »